The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of the c-Met inhibitor tepotinib in advanced lung adenocarcinoma with MET exon 14 skipping mutations.
 
Paul K. Paik
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis
 
Remi Veillon
No Relationships to Disclose
 
Jürgen Scheele
Employment - Merck KGaA
Research Funding - Merck KGaA
 
Rolf Bruns
Employment - Merck KGaA
Research Funding - Merck KGaA